PT-141 is a unique, non-hormonal peptide therapy that acts on the melanocortin system in the central nervous system. Unlike hormone-based treatments, it targets neural pathways involved in sexual arousal and desire. Its approved and research applications focus on supporting healthy sexual function by acting on specific brain receptors (MC4R), offering a distinct mechanism for addressing aspects of sexual wellness.